mastodynon perorální kapky, roztok
bionorica se, neumarkt array - 50083 agnus castus 1 d; 50500 caulophyllum thalictroides 4 d; 50277 cyclamen europaeum 4 d; 50501 strychnos ignatii 6 d; 50502 iris versicolor 2 d; 50503 lilium tigrinum 3 d - perorální kapky, roztok - fytofarmaka a ŽivoČiŠnÉ produkty (ČeskÁ atc skupina)
ablavar (previously vasovist)
tmc pharma services ltd. - gadofosveset trisodné - magnetická rezonanční angiografie - kontrastní média - tento léčivý přípravek je určen pouze pro diagnostické účely. ablavar je indikován pro kontrast-lepší magnetické rezonance angiografie (ce-mra), pro vizualizaci břicha nebo končetin cév u dospělých, nebo u nichž existuje podezření cévní onemocnění.
amisulprid viatris 200mg tableta
mylan ireland limited, dublin array - 8840 amisulprid - tableta - 200mg - amisulprid
amisulprid viatris 50mg tableta
mylan ireland limited, dublin array - 8840 amisulprid - tableta - 50mg - amisulprid
sertralin mylan 100mg potahovaná tableta
viatris limited, dublin array - 13950 sertralin-hydrochlorid - potahovaná tableta - 100mg - sertralin
sertralin mylan 50mg potahovaná tableta
viatris limited, dublin array - 13950 sertralin-hydrochlorid - potahovaná tableta - 50mg - sertralin
taris 0,5mg/0,4mg tvrdá tobolka
viatris limited, dublin array - 15483 dutasterid; 14672 tamsulosin-hydrochlorid - tvrdá tobolka - 0,5mg/0,4mg - tamsulosin a dutasterid
cholib
viatris healthcare limited - fenofibrát, simvastatin - dyslipidémie - Činidla modifikující lipidy - přípravek cholib je indikován jako přídatná léčba k dietě a cvičení u dospělých pacientů vysoké kardiovaskulární riziko s smíšené dyslipidemie snížit triglyceridy a zvýšit hladiny hdl cholesterolu, když hladiny ldl cholesterolu jsou náležitě kontrolována s odpovídající dávku simvastatinem.
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidla - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
acnatac 10mg/g+0,25mg/g gel
viatris healthcare limited, dublin array - 2126 klindamycin-fosfÁt; 1958 tretinoin - gel - 10mg/g+0,25mg/g - tretinoin, kombinace